You are here

  • Home
  • Archive
  • Volume 77, Issue 5
  • Lupus Low Disease Activity State (LLDAS) attainment discriminates responders in a systemic lupus erythematosus trial: post-hoc analysis of the Phase IIb MUSE trial of anifrolumab

Article metrics

Article menu

Download PDFPDF

Clinical and epidemiological research
Extended report
Lupus Low Disease Activity State (LLDAS) attainment discriminates responders in a systemic lupus erythematosus trial: post-hoc analysis of the Phase IIb MUSE trial of anifrolumab

 

Online download statistics by month:

Online download statistics by month: February 2018 to March 2024

AbstractFullPdf
Feb 2018685705220
Mar 201836542196
Apr 2018517517127
May 201834034692
Jun 201821722269
Jul 201830330370
Aug 201816516549
Sep 201816316337
Oct 201817217236
Nov 201822222242
Dec 201812212219
Jan 201914814838
Feb 201915014844
Mar 201911611234
Apr 201918017137
May 201915415252
Jun 201915114732
Jul 201916915528
Aug 201914412836
Sep 201915515041
Oct 201920520531
Nov 201917216851
Dec 201913713740
Jan 202013813132
Feb 2020969253
Mar 2020939131
Apr 202013713336
May 202011411038
Jun 202013113046
Jul 2020949437
Aug 2020878625
Sep 202013313134
Oct 202010710536
Nov 2020777332
Dec 2020787221
Jan 2021978822
Feb 20211009729
Mar 202110710435
Apr 202111511229
May 202113813631
Jun 202114113454
Jul 2021999419
Aug 20211089638
Sep 202111911143
Oct 202111310158
Nov 2021928850
Dec 2021868641
Jan 202210910524
Feb 202210010129
Mar 2022797238
Apr 202210810339
May 2022989566
Jun 202211310345
Jul 2022868128
Aug 202211711160
Sep 202212211840
Oct 2022968744
Nov 2022938262
Dec 2022747232
Jan 2023898134
Feb 202311211157
Mar 2023746735
Apr 2023888047
May 2023928436
Jun 202312912631
Jul 2023807841
Aug 202311110926
Sep 202311011025
Oct 202322922732
Nov 202344338223
Dec 202312512237
Jan 202411410821
Feb 2024787321
Mar 2024514875
Total10872106103239